Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Clinical significance of time interval between surgery and adjuvant chemotherapy in patients with gastric cancer after gastrectomy: A population-based cohort study using a nationwide claims database.
Authors
Chi Hoon Maeng
Department of Medicine, Division of Medical Oncology-Hematology, Kyung Hee University Hospital, Seoul, South Korea
Chi Hoon Maeng , Hoseob Kim , Mina Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 333)
DOI
10.1200/JCO.2024.42.3_suppl.333
Abstract #
333
Poster Bd #
F13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Adjuvant chemotherapy for older patients with stage II/III gastric cancer: A retrospective cohort study.
First Author: Yu-Hsuan Shih
Poster
2016 ASCO Annual Meeting
Impact of earlier adjuvant chemotherapy after surgery on prognosis in patients with operable gastric cancer: A propensity score matched analysis.
First Author: Mi-Jung Kim
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Tumor regression grade after neoadjuvant chemotherapy in patients with locally advanced gastric cancer treated with modern chemotherapy (FLOT): Experience in patients in Guatemala.
First Author: Rixci Ramirez
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prospective cohort study of patients with stage III colorectal cancer aged ≥ 80 years who underwent curative resection: The HiSCO-04 study.
First Author: Manabu Shimomura Sr.